NIAID director Anthony Fauci discusses AIDS vaccine
In an early-morning announcement today, researchers reported that an experimental HIV (human immunodeficiency virus) vaccine effectively reduced the number of people who contracted the virus by nearly a third.
The U.S. National Institutes of Health (NIH) this week canceled plans for a large clinical trial of an experimental vaccine to combat the human immunodeficiency virus (HIV).
Until now, the news on HIV microbicides—gels, creams and foams applied to the vagina and rectum to prevent transmission of the disease—has been dismal.
Record flooding in Louisiana may promote spread of the virus
What would it take to hijack the virus in west Africa and turn it into a bioterror agent elsewhere?
The infant was placed back on medication but the clinical trial to replicate virus suppression is still expected to proceed
Angiogenesis¿the formation of new blood vessels¿might one day be manipulated to treat disorders from cancer to heart disease. First-generation drugs are now in the final phase of human testing
An NIH-backed vaccine is among several heading for human trials, but the timeline for large-scale deployment remains murky
We unpack whether a controversial prevention method works
New global clinical trial aims to replicate the mysterious “Mississippi baby” success
Dwindling infection rate makes reliable data hard to gather
The maverick malaria vaccine achieves 100 percent protection using parasites from irradiated mosquitoes
Encouraging results in the search for an AIDS vaccine
A new analysis identifies targets for an immune response that could improve AIDS vaccines
The results are the first from a randomized, controlled trial of the treatment
Would killing some T cells slow the progress of AIDS?
Scientists and policymakers argue that publishing full H5N1 ferret papers is important for protecting humanity against future pandemics